Medicinal Genomics

About

Medicinal Genomics is a biotechnology company based in Beverly, Massachusetts, with scientific operations in Amsterdam, Netherlands. Founded in 2011, the company specializes in cannabis and medicinal plant genomics, focusing on enhancing cannabis safety, quality, and genetic research through advanced genomic technologies. The company offers a range of services, including genomic sequencing for cannabis and *Psilocybe cubensis*, microbial detection to identify contaminants, and strain authentication to verify cannabis strain authenticity. Medicinal Genomics has made significant contributions to the field, being the first to sequence the full genomes of *Cannabis sativa* and *Cannabis indica*, and has generated a vast amount of genomic data. Their cloud-based data access allows users to access raw genomic data and utilize annotation tools. With around 40 employees and generating approximately $10 million in revenue, Medicinal Genomics plays a vital role in ensuring cannabis safety and advancing genetic research for medical and commercial purposes.